VALPROMIDE/CARBAMAZEPINE AND RISK OF TERATOGENICITY
- 16 February 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 325 (8425) , 397-398
- https://doi.org/10.1016/s0140-6736(85)91417-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Carbamazepine Metabolism in ManClinical Pharmacokinetics, 1985
- Potent Therapeutic Effect of Carbamazepine-10,11-Epoxide in Trigeminal NeuralgiaArchives of Neurology, 1984
- POSSIBLE HAZARD OF VALPROMIDE-CARBAMAZEPINE COMBINATION THERAPY IN EPILEPSYThe Lancet, 1984
- Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine)Epilepsia, 1984
- Single-dose kinetics and metabolism of carbamazepine-10,11-epoxideClinical Pharmacology & Therapeutics, 1983
- Influence of carbamazepine 10, 11-oxide on drug metabolizing enzymesBiochemical Pharmacology, 1980
- Kinetics of carbamazepine and its 10,11‐epoxide metabolite in childrenClinical Pharmacology & Therapeutics, 1976
- Formation of Stable Epoxides in the Metabolism of Tricyclic DrugsDrug Metabolism Reviews, 1976
- Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicityInternational Journal of Cancer, 1975